Neurotox Res (2009) 16:306–317 Arispe N, Pollard HB, Rojas E (1996) Zn2? interaction with Alzheimer amyloid beta protein calcium channels. Proc Natl Acad Sci USA 93:1710–1715 Ashford JW (2004) APOE genotype effects on Alzheimer’s disease onset and epidemiology. J Mol Neurosci 23:157–165 Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481–489 Bar-On P, Rockenstein E, Adame A, Ho G, Hashimoto M, Masliah E (2006) Effects of the cholesterol-lowering compound methyl- beta-cyclodextrin in models of alpha-synucleinopathy. J Neuro- chem 98:1032–1045 Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, Masliah E (2008) Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson’s disease. J Neuro- chem 105:1656–1667 Borchelt D, Thinakaran G, Eckman C, Lee M, Davenport F, Ratovitsky T, Prada C, Kim G, Seekins S, Yager D (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Ab1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005–1013 Borchelt D, Ratovitski T, van Lare J, Lee M, Gonzales V, Jenkins N, Copeland N, Price D, Sisodia S (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutamt presenilin 1 and amyloid precursor proteins. Neuron 19:939–945 Bornemann KD, Staufenbiel M (2000) Transgenic mouse models of Alzheimer’s disease. Ann N Y Acad Sci 908:260–266 Bouillot C, Prochiantz A, Rougon G, Allinquant B (1996) Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J Biol Chem 271:7640–7644 Braak H, Braak E (1994) Morphological criteria for the recognition of Alzheimer’s disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 15:355–356 discussion 379–380 Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22:8797–8807 Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4:233–234 Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383–396 Cheng IH, Palop JJ, Esposito LA, Bien-Ly N, Yan F, Mucke L (2004) Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 10:1190–1192 Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D (2001) Early-onset amyloid deposition and cogni- tive deﬁcits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276:21562– 21570 Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Subert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Hong Y, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St.George Hyslop P, Selkoe D (1997) Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67–72 Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249–254 313 Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro ﬁbril formation by a mutant alpha-synuclein linked to early- onset Parkinson disease. Nat Med 4:1318–1320 Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW (1997) Alzheimer’s A beta(1-42) is generated in the endoplasmic reticulum/intermediate compart- ment of NT2N cells. Nat Med 3:1021–1023 Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jakala P, Hartmann T, Beyreuther K, Masters CL, Li QX (1999) Non- Abeta component of Alzheimer’s disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am J Pathol 155:1173–1181 Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007) Different species of alpha-synuclein oligomers induce calcium inﬂux and seeding. J Neurosci 27:9220–9232 Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278–288 Ding TT, Lee SJ, Rochet JC, Lansbury PT Jr (2002) Annular alpha- synuclein protoﬁbrils are produced when spherical protoﬁbrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41:10209–10217 Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210 Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM, Oxford JT, Feany MB, Masliah E, Rohn TT (2007) Calpain-cleavage of {alpha}-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol 170:1725–1738 Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307:1061–1073 Fernagut PO, Chesselet MF (2004) Alpha-synuclein and transgenic mouse models. Neurobiol Dis 17:123–130 Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24:9434–9440 Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of alpha- synuclein. J Neurosci 24:6715–6723 Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemes J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya- Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F b-amyloid precursor protein. Nature 373:523–527 Games D, Masliah E, Lee M, Johnson-Wood K, Schenk D (1997) Neurodegenerative Alzheimer-like pathology in PDAPP 717V ? F transgenic mice. In: Hyman B, Duyckaerts C, Christen Y (eds) Connections, cognition and Alzheimer’s disease. Springer-Verlag, Berlin, pp 105–119 Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuc- lein nitration in synucleinopathy lesions. Science 290:985–989 Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement 123